Sanofi
(NASDAQ: SNY)
|
9:00 PM UTC, 11/19/24 | |||
---|---|---|---|---|
Last: $48.00 | Change: -0.51 | %Change: -1.05% | Volume: 2,910,806 |
Open: | $ 47.98 | Volume: | 2,910,806 | |
---|---|---|---|---|
High: | $ 48.21 | Yield(%) | 3.05 | |
Low: | $ 47.84 | P/E Ratio (ttm): | 26.61 | |
Dividend ($): | 1.48 | Market Cap ($): | 121.62B | |
EPS ($) | 2.12 | Shares Out: | 2.51B |
% Price Change (last 4 weeks): | -9.60 |
---|---|
% Price Change (last 13 weeks): | -11.02 |
% Price Change (last 26 weeks): | 0.19 |
% Price Change (last 52 weeks): | 4.32 |
% Price Change (year to date): | -2.45 |
Return on Equity (%): | 7.23 |
---|---|
Return on Assets (%): | 4.25 |
Return on Invested Capital (%): | 8.06 |
Gross Profit Margin (%): | 61.52 |
---|---|
Net Profit Margin (%): | 12.54 |
Operating Profit Margin (%): | 21.32 |
50-day Moving Average: | $54.45 |
---|---|
200-day Moving Average: | $50.84 |
Avg. Daily Vol. (last 50 days): | 1,932,247 |
Avg. Daily Vol. (last 200 days): | 2,064,009 |
52-wk high: | $58.97 |
52-wk low: | $45.22 |
Bid: | $47.60 |
Ask: | $48.50 |
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
|
Sanofi
46, avenue de la Grande Armée Paris IF 75017 Phone: 33.1.53.77.40.00 Fax: 33.1.53.77.44.03 http://www.sanofi.com |
Earnings (1year) ($): | 1.82 |
---|---|
Annual Dividend ($): | 1.48 |
Current P/E Ratio (ttm): | 26.61 |
Book Value ($): | 32.68 |
Cash Flow ($): | 3.96 |
Price/Earnings (x): | 26.61 |
---|---|
Price/Sales (x): | 2.68 |
Price/Book (x): | 1.52 |
Price/Cash Flow (x): | 11.27 |
Quick Ratio (x): | 0.87 |
---|---|
Current Ratio (x): | 1.27 |
LT Debt/Equity (x): | 21.75 |
Total Debt/Equity (x): | 24.88 |